TWO SIGMA INVESTMENTS, LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$40,755
-80.8%
309,217
-25.8%
0.00%
-100.0%
Q2 2023$212,512
-65.6%
416,690
-57.5%
0.00%
-50.0%
Q1 2023$618,005
-41.8%
980,960
-40.1%
0.00%
-33.3%
Q4 2022$1,062,462
+44.7%
1,636,823
+283.4%
0.00%
+50.0%
Q3 2022$734,000
+28.5%
426,909
-7.3%
0.00%0.0%
Q2 2022$571,000
-50.9%
460,762
-74.2%
0.00%
-33.3%
Q1 2022$1,163,000
-59.4%
1,782,618
-32.2%
0.00%
-50.0%
Q4 2021$2,867,000
+245.8%
2,630,282
+477.4%
0.01%
+200.0%
Q3 2021$829,000
-61.9%
455,567
-44.8%
0.00%
-60.0%
Q2 2021$2,178,000
-37.7%
824,835
-15.0%
0.01%
-44.4%
Q1 2021$3,494,000
+62.0%
970,480
+13.4%
0.01%
+50.0%
Q4 2020$2,157,000
+11.5%
855,841
+11.5%
0.01%
-14.3%
Q3 2020$1,934,000
+3416.4%
767,549
+4452.2%
0.01%
Q2 2020$55,000
-95.0%
16,861
-96.2%
0.00%
-100.0%
Q1 2020$1,096,000
+82.1%
447,251
+250.7%
0.01%
+350.0%
Q4 2019$602,000
+32.9%
127,528
+20.6%
0.00%0.0%
Q3 2019$453,000
+113.7%
105,756
-6.8%
0.00%
+100.0%
Q4 2018$212,000
-74.4%
113,462
+64.6%
0.00%
-75.0%
Q2 2015$827,000
-73.5%
68,939
-76.2%
0.00%
-73.3%
Q1 2015$3,120,000
+1994.0%
289,730
+788.6%
0.02%
+1400.0%
Q1 2014$149,00032,6050.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders